Single-Cell Transcriptome Analysis of Small Cell Neuroendocrine Carcinoma of the Endometrium Reveals ISL1 as a Potential Biomarker for Diagnosis and Treatment.
Zhong C, Guo YE, Yang Q, Song Y, Wang T, Cai B, Chen H, Du H, Wan J, Liu Y, Li Y, Wan X.
Front Biosci (Landmark Ed). 2024 Mar 13;29(3):100. doi: 10.31083/j.fbl2903100.
PMID:38538277
Small cell carcinoma of the gynecologic tract: a multifaceted spectrum of lesions.
Atienza-Amores M, Guerini-Rocco E, Soslow RA, Park KJ, Weigelt B.
Gynecol Oncol. 2014 Aug;134(2):410-8. doi: 10.1016/j.ygyno.2014.05.017. Epub 2014 May 27.
PMID:24875120
Immunohistochemical analysis of SOX2 expression in small-cell neuroendocrine carcinoma of the endometrium.
Ebisu Y, Ishida M, Mizokami T, Kita M, Okada H, Tsuta K.
2004 Feb 5 [updated 2021 Feb 4]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024.
PMID:20301390
Small-cell neuroendocrine carcinoma of the female genital tract: A comprehensive overview.